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Advanced maternal age 
compromises fetal growth and 
induces sex-specific changes in 
placental phenotype in rats
tina napso1, Yin-po Hung1, Sandra t. Davidge2, Alison S. care2,3,4 & Amanda n. Sferruzzi-perri1,4*
Advanced maternal age is associated with an increased risk of pregnancy complications. it programmes 
sex-specific cardiovascular dysfunction in rat offspring, however the intrauterine mechanisms involved 
remain unknown. this study in the rat assessed the impact of advanced maternal age on placental 
phenotype in relation to the growth of female and male fetuses. We show that relative to young (3–4 
months) dams, advanced maternal age (9.5–10 months) compromises growth of both female and 
male fetuses but affects the placental phenotype sex-specifically. In placentas from aged versus young 
dams, the size of the placental transport and endocrine zones were increased and expression of Igf2 
(+41%) and placental lactogen (Prl3b1: +59%) genes were upregulated in female, but not male fetuses. 
Placental abundance of IGF2 protein also decreased in the placenta of males only (−95%). Moreover, in 
placentas from aged versus young dams, glucocorticoid metabolism (11β-hsd2: +63% and 11β-hsd1: 
−33%) was higher in females, but lower in males (11β-hsd2: −50% and 11β-hsd1: unaltered). there 
was however, no change in the placental abundance of 11β-HSD2 protein in aged versus young dams 
regardless of fetal sex. Levels of oxidative stress in the placenta were increased in female and male 
fetuses (+57% and +90%, respectively) and apoptosis increased specifically in the placenta of males 
from aged rat dams (+700%). Thus, advanced maternal age alters placental phenotype in a sex-specific 
fashion. these sexually-divergent changes may play a role in determining health outcomes of female 
and male offspring of aged mothers.
Pregnancy at an advanced maternal age (≥35 years of age) is increasing, particularly in developed countries. For 
instance, in the USA, Canada, UK and Australia, births to women 35 years and older constitute 14–22% of total 
live births1,2. Birth at an advanced maternal age involves higher risks for both mothers and babies, including an 
increased risk of developing complications such as gestational diabetes, placenta praevia, gestational hyperten-
sion, stillbirth and caesarean section delivery3,4. Furthermore, advanced maternal age is an independent risk 
factor for the development of preeclampsia5. Epidemiological data demonstrate that infants born to older mothers 
are more likely to be born preterm or small for gestational age6. Moreover, there are higher levels of fetal congen-
ital anomalies and chromosomal abnormalities7.
Advanced maternal age can also affect the intrauterine environment, with previous studies showing an 
impaired decidual reaction and reduced uterine prostaglandin synthesis8, as well as increased loss during the 
peri-implantation period9. There are also changes in the microstructure of the uterine luminal epithelium, par-
ticularly in the microvillous architecture8,10. These changes may affect the ability of the blastocyst to attach and of 
trophoblast cells to invade into the underlying decidua8. In addition, impaired oocyte developmental potential 
and a suboptimal intrauterine environment contribute to reduced embryo developmental competence, all of 
which have been described in advanced maternal age8,11. Aging also affects the immune cell population in the 
decidua and the uterine response to hormones that invoke decidualisation in the mouse and lead to impaired 
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embryonic and placental development12. These effects appear to be independent of the oocyte and embryo, as 
they could be largely rescued by transferring mouse embryos from older dams to young dams12.
We have previously described that placental weight is increased in advanced maternal age rats, which is con-
sistent with other studies in advanced maternal age mice13 and women3–6,14–16. There is substantial evidence in 
other rodent models to suggest that placental structure, transport and endocrine function, are regulated by the 
maternal environment and that adverse conditions such as maternal over or under-nutrition, micro and macro-
nutrient deficiency, obesity and hypoxia alter these sensitive processes17. Moreover, in many of these conditions, 
there are alterations in the ability of the placenta to protect the fetus from circulating maternal glucocorticoids, 
which in turn, can profoundly affect fetal development and later offspring health18–20. However, limited informa-
tion is available on how placental structure and function is altered by advanced maternal age.
In women of advanced maternal age, placental transport capacity is increased16. In a study that assessed 
placental function in mice, the amino acid transport capacity in placentae from advanced maternal age mice 
(14C-methyl amino isobutyric acid and 3H-taurine clearance) is decreased13. Furthermore, advanced maternal age 
has been shown to alter the main direction of placentation and the trophoblast compartment in the mouse12. It is 
becoming increasingly evident that fetal sex influences placental and offspring outcomes in response to adverse 
maternal environments during gestation21,22. However, little information is available about whether advanced 
maternal age leads to any sex-specific changes in placental structure and functional capacity. Such sex-specific 
changes in placental phenotype may be linked to the early-life programming of cardiovascular disease suscepti-
bility in offspring born of aged dams, which we have shown to be sex-dependent23,24.
We hypothesized that the reduced fetal weight and impaired pregnancy success observed in our rat model of 
advanced maternal age, may be due to sex-specific alterations in placental morphological development and nutri-
ent transport function. Here we show that advanced maternal age affects placental development and functional 
capacity in a sex-dependant fashion in the rat.
Results
Advanced age affects maternal metabolic phenotype during pregnancy. Young (3–4 months old) 
or aged (9.5–10 months old) Sprague Dawley female rats were time-mated with young male Sprague Dawley rats 
(3–5 months old) and the impact of advanced maternal age on maternal metabolic physiology and conceptus 
development were evaluated on gestational day (GD) 20. In a previously published study using this cohort, we 
showed that aged dams had greater fat percentage and gross body weight compared to young dams, together with 
changes in uterine artery function in late pregnancy25. To further indicate maternal metabolic state, in this study, 
we evaluated serum metabolite and hormone concentrations in aged versus young dams. Glucose concentration 
in the maternal serum was elevated by 11% in aged dams compared to young (p < 0.05, Table 1). However, serum 
insulin, leptin, cholesterol and free fatty acid concentrations were not altered by advanced maternal age (Table 1).
Advanced maternal age reduces fetal weight and placenta efficiency. We have previously reported 
that in aged dams, litter size was reduced and greater fetal loss was observed compared to young dams25. Here we 
show that in the subset of dams assessed in this study, weight distribution curves for viable fetuses are shifted to 
the left towards the lower fetal weight range in aged dams (Fig. 1A). Indeed, more than half of the fetuses (55%) 
from aged dams displayed a weight below the 5th centile for young dams (Fig. 1A).When accounting for fetal sex, 
average weight of both female and male fetuses was reduced by ~20–25% in aged dams compared to young dams 
(Fig. 1D,G). The reduction in fetal weight in aged dams was associated with significant decrease in the absolute 
weight of heart, brain and liver in males (p < 0.0 5) but not in females (Table 2). There was however, no effect of 
maternal age on the relative weight of any fetal organ analysed in male or females, suggesting that fetuses were 
symmetrically growth restricted (Table 2). Advanced maternal age did not affect placental weight or placental 
weight distribution (Fig. 1B,E,H). However, there was an overall leftward shift in placental efficiency distribu-
tion (estimated as the ratio of fetal weight to placental weight) (Fig. 1C) and placental efficiency was reduced by 
22% for females and 37% for male fetuses from aged versus young dams (p < 0.01 and p < 0.001, respectively; 
Fig. 1F,I). Thus, advanced maternal age compromises fetal development and placental efficiency.
Advanced maternal age alters placental structure. To determine whether the reduction in placental 
efficiency in aged dams may be related to morphological changes to the placenta, we analysed placental structure 
from female and male fetuses using stereology (Fig. 2A,B). The estimated volumes of the placental endocrine 
junctional zone (Jz) and transport labyrinthine zone (Lz) were increased for female, but not male fetuses in aged 
Young Aged t-test
Insulin (ug/L) 7.39 ± 2.9 3.76 ± 0.5 p = 0.25
Leptin (pg/ml) 2455.8 ± 467 5367 ± 1670 p = 0.124
Glucose (mmol/l) 6.97 ± 0.06 7.73 ± 0.29* p = 0.04
Cholesterol (mmol/l) 1.95 ± 0.09 1.75 ± 0.11 p = 0.2
FFA (umol/l) 1211.1 ± 267 1098.8 ± 95 p = 0.7
Table 1. Serum hormone and metabolite concentrations in young and aged dams. Data presented as 
mean ± SEM. Data are from young or aged females (n = 6 females per group). *Significant difference between 
groups by unpaired t test (p < 0.05).
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versus young dams (p < 0.05; Fig. 2C). The volumes of the maternal decidua and the placental chorion were not 
affected by maternal age in either female or male fetuses.
In the Jz, the volume of the spongiotrophoblast cells (Sp-T) was increased by 13% in females and 70% in male 
fetuses of aged compared to young dams (p < 0.001; Fig. 2D). The volume of glycogen cells (GlyT) and giant cells 
(G-T) in the placental Jz were not altered by maternal age in either female or male fetuses. However, in male 
fetuses but not females, the cell size of the Gly-T was significantly increased in aged dams compared to male pla-
centas from young dams (p < 0.05, Fig. 2F).
In the Lz of female, but not male fetuses, the estimated volumes of fetal capillary (FC) and trophoblast trended 
towards an increase in aged versus young dams (both p = 0.06; Fig. 2E). In both female and male fetuses, the vol-
umes of maternal blood spaces and trophoblast in the Lz were similar between aged and young dams (Fig. 2E). 
There was no effect of maternal age on FC length and diameter (Fig. 2G,H), thickness of trophoblast barrier to 
diffusion, surface area for exchange or the theoretical capacity for diffusion of molecules like oxygen (Table 3) in 
either female or male pups in aged versus young dams. Taken together, these data indicate that advanced maternal 
Figure 1. Fetal and placental weights in young versus aged dams. Distribution curves for fetal weight (A), 
placental weight (B) and placental efficiency (C) shown independent of fetal sex. Vertical solid line represents 
the 5th centile of the young curve (3.345 g, 0.416 g and 5.28 in A, B and C, respectively). Fetal weight (D,G), 
placental weight (F,H) and placental efficiency (E,I) for female and male fetuses, respectively. Data displayed 
as mean + SEM and are from 9–20 fetuses and placentas from 9–12 dams per group (1–2 conceptuses per litter 
used). Statistical difference between young and aged dams was determined by unpaired student t test, *p < 0.05, 
**p < 0.01 ***p < 0.001.
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age affects placental structure in a sex-dependant manner. However, the changes in placental structure do not 
appear to completely explain the reduction in placental efficiency observed in aged dams.
Advanced maternal age changes placental gene and protein expression in both female and 
male fetuses. To further examine the mechanisms underlying impaired placental efficiency in aged dams, 
we quantified the placental expression of growth-regulatory genes (Igf2, Vegf and p53), system A amino acid 
(Slc38a) transporters, glucose transporters (Slc2a), hormones (placental lactogens 1 and 2: Prl3d1 and Prl3b1) 
and enzymes which metabolise and control glucocorticoid actions in the conceptus (11β-hsd1 and 11β-hsd2, 
which increase and reduce glucocorticoid activity, respectively). In female, but not male fetuses, placental mRNA 
expression of Igf2, Prl3b1 and 11β-hsd2 were increased, whereas 11β-hsd1 was reduced in aged compared to 
young dams (p < 0.05; Fig. 3A–D). In male fetuses, advanced maternal age reduced placental Vegf and 11β-hsd2 
expression without affecting the expression of other genes assessed (p < 0.05; Fig. 3A–D).
In males, the abundance of IGF2 protein in the placenta was significantly reduced, but unaltered in females by 
advanced maternal age (Fig. 3F). VEGF abundance was reduced by ~50% in the placenta of both female and male 
fetuses of aged dams (Fig. 3G). However, the placenta abundance of 11β-HSD2 protein tended to be elevated in 
females (p = 0.19) and not altered in the placenta of males from aged dams (Fig. 3H). These data demonstrate that 
advanced maternal age affects the expression of genes and proteins that control the growth and function of the 
placenta in a manner that depends partially on fetal sex.
Advanced maternal age is associated with increased levels of placental oxidative stress and 
apoptosis in male but not female fetuses. Elevated levels of oxidative stress have been reported in 
the placenta of compromised human pregnancies and in experimental animals exposed to adverse gestational 
environments26–28. It can result from an imbalance between prooxidant and antioxidant systems and lead to apop-
tosis. Hence, the abundance of oxidative stress, antioxidant enzymes and apoptosis was assessed in the placenta 
of female and male fetuses of aged versus young dams. In aged compared to young dams, the level of protein 
carbonylation, a marker of oxidative stress was increased by ~57% and ~90% in the placenta of female and male 
fetuses, respectively (p < 0.05; Fig. 4A,B). The abundance of antioxidant enzymes, anti-glutathione peroxidase 
1 (GPX1) and superoxide dismutase-2 (SOD2) in the placenta of either female or male pups were not different 
with maternal age. In placentas from female fetuses, the abundance of another antioxidant, catalase (CAT) was 
reduced by 30% (p < 0.01) whereas only a trend towards a reduction was observed in males (p < 0.06) (Fig. 4C,D). 
The abundance of cleaved caspase, an indicator of apoptosis was elevated in the placental Jz of male, but not 
female fetuses from aged dams (p < 0.05; Fig. 4E,G). The abundance of cleaved caspase in the placental Lz was 
not affected by maternal age in either female or male fetuses (Fig. 4F,H). Activation of the end stage of apoptosis, 
indicated by TMR red staining in the placental Jz was not significantly different with maternal age, regardless of 
sex (Fig. 4I,J). There was no TMR red staining detected in the placenta Lz. Thus, advanced maternal age increases 
oxidative stress in the placenta of female and male fetuses, with placentas only from males showing elevated levels 
of apoptosis in the Jz.
Discussion
This study demonstrates that advanced maternal age modifies placental phenotype and hence its ability to support 
fetal growth. In particular, it affects placental morphological development and expression of genes and proteins 
fundamentally important in placental growth, nutrient transfer, endocrine control of maternal physiology and 
control of fetal glucocorticoid exposure. Advanced maternal age induces oxidative stress and cell death in the pla-
centa, in a partially sex-dependent manner. Moreover, gene expression changes in the placentas of female fetuses 
were largely beneficial, with an upregulation of genes that support placental function. However, gene expression 
changes in placentae of male fetuses were generally detrimental for placental growth and functional phenotype in 
aged dams. Both female and male fetuses were similarly growth restricted, although absolute weight of male fetal 
heart, brain and liver were reduced in aged dams versus young dams. Moreover, our previous studies have shown 
poorer cardiovascular outcomes for adult male offspring from aged dams24. Taken together, our data demonstrate 
Female Male
Young Aged Young Aged
Heart (g) 0.025 ± 0.001 0.022 ± 0.0008 0.026 ± 0.0008 0.022 ± 0.0007*
Heart (% of Fw) 0.669 ± 0.04 0.660 ± 0.03 0.650 ± 0.02 0.641 ± 0.03
Brain (g) 0.186 ± 0.003 0.176 ± 0.002 0.193 ± 0.002 0.174 ± 0.004*
Brain (% of Fw) 4.9 ± 0.07 5.2 ± 0.18 4.8 ± 0.09 5.0 ± 0.19
Liver (g) 0.331 ± 0.007 0.356 ± 0.011 0.308 ± 0.016 0.310 ± 0.016*
Liver (% of Fw) 8.71 ± 0.20 9.16 ± 0.56 8.94 ± 0.19 8.96 ± 0.26
Kidney (g) 0.028 ± 0.002 0.031 ± 0.0009 0.026 ± 0.0007 0.029 ± 0.001
Kidney (% of Fw) 0.73 ± 0.05 0.77 ± 0.02 0.80 ± 0.02 0.84 ± 0.02
Brain/Liver 0.56 ± 0.016 0.54 ± 0.016 0.58 ± 0.029 0.56 ± 0.023
Table 2. Fetal organ weights in young versus aged dams. Data presented as mean ± SEM. Data are from 7 
fetuses per sex from 4–5 dams per group. Fw: fetal weight. Significant difference for maternal age within one sex 
was determined by unpaired t test, *p < 0.05.
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that the effects of advanced maternal age on fetal growth and also later-life offspring health may be mediated, at 
least in part, by sexually-dimorphic changes in the placenta during pregnancy. These findings may have relevance 
for developing targeted interventions to improve placental development and function and thus the fetal growth 
and development trajectory for mothers of advanced maternal age.
Placental development and expression of genes and proteins that impact the function of the endocrine Jz 
in the placenta was altered in aged dams. The spongiotrophoblast compartment was larger in the placenta of 
both female and male fetuses of aged dams, whereas the glycogen cells were significantly larger in size only in 
Figure 2. Placental morphology in young versus aged dams. Representative images of haematoxylin and eosin 
stained placentas (A). Representative images of placentas showing the low and high magnification structure 
of the labyrinthine zone by immuno-staining for laminin and cytokeratin (B-1), as well as the structure of 
the junctional zone by staining with haematoxylin and eosin (B-2). Placental region volumes (C), junctional 
zone cell volumes (D), labyrinthine zone compartment volumes (E), glycogen cell size (F) and labyrinthine 
fetal vessel length (G) and diameter (H) in females and males. Data are from 4 placentas per group, each from 
different litter and presented as mean + SEM values. Significant difference between young and aged dams 
were determined by unpaired student t test, *p < 0.05. Ch: chorion, Db: decidua, FC: fetal capillaries, G-T: 
giant cells, Gly-T: glycogen cells, Jz: junctional zone, Lz: labyrinthine zone, MBS: maternal blood spaces, Sp-T: 
spongiotrophoblast, Troph: trophoblast.
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the male placenta of the aged dams, the latter of which may reflect a more advanced Jz phenotype29. These Jz 
changes would be expected to have enhanced the placental capacity to secrete hormones30 as well as potentially 
provided a larger supply of stored glucose (as glycogen) for generating energy for the final phase of fetal growth31 
in aged dams. However, in male fetuses of aged dams there were reduced IGF2 abundance and elevated expres-
sion of apoptosis markers in the Jz, particularly in the spongiotrophoblast, which may have compromised the 
functional capacity of the Jz, even if they were in greater volume. In females, but not males, placental expression 
of Prl3b1, which encodes placental lactogen 2 was increased in line with spongiotrophoblast expansion32. This 
finding is consistent with work in mice which found enhanced expression of placental lactogen genes in aged 
dams, although sex-related effects were not investigated12. Placental hormones such as placental lactogen and 
IGF2, change pancreatic β-cell function and reduce insulin sensitivity and glucose utilisation in the mother33–35. 
Changes in glucose handling of the placenta may be exacerbated by, or related to, the elevated circulating glucose 
concentration observed in our aged rat dams. Future studies are needed to determine the interaction between an 
altered maternal metabolic state and changes in the endocrine placental Jz during gestation. This may enhance 
our understanding of why pregnancy at an advanced maternal age is associated with an increased risk of gesta-
tional diabetes in women4. Taken together, our data suggest that endocrine function of placentas from female 
fetuses, and to a lesser extent, placentas from male fetuses, adapt in response to the altered gestational environ-
ment in aged compared to young rat dams. Our data are consistent with other reports that demonstrate beneficial 
changes in placental endocrine phenotype with other adverse gestational environments that compromise the 
ability of the mother to support conceptus development in rodents36–40.
The volume of the Lz was significantly increased in placentas from female fetuses from aged dams. However, 
placental expression of amino acid transporters was unchanged in both female and male fetuses in aged, com-
pared to young dams. Furthermore, in both female and male fetuses, placental expression of glucose transporters 
(Slc2a1 and Slc2a3) was not compromised by advanced maternal age, unlike other adverse maternal conditions 
in rodents and women, such as excess glucocorticoids, malnutrition, obesity, hyperglycemia and hypoxia41–47. 
Interestingly, placental abundance of VEGF was diminished in both female and male pups from aged dams. 
Changes in VEGF expression with maternal age may affect vascular branching in the placental Lz, with down-
stream consequences for blood supply and oxidation levels in the placenta, as well as fetal growth48. Indeed, 
advanced maternal age increased levels of oxidative stress in the placenta in both sexes. The reduced VEGF and 
increased oxidative stress in the placenta are consistent with the altered uterine and umbilical artery function that 
may diminish the supply of blood to the placenta and fetus in aged rat dams in late pregnancy25. However, the lev-
els of oxidative stress in the placenta were increased to a greater extent in male fetuses when compared to female 
fetuses in aged dams. This was despite the observation that placentas from female but not male fetuses showed 
reduced abundance of the antioxidant protein, catalase/CAT in aged dams (there was no effect of maternal age on 
the abundance of GPX1 or SOD2 protein). Our observation are in line with previous studies showing increased 
oxidative stress in placentas from aged dams resulting in fetal growth restriction13,49.
Changes in the endocrine and transport phenotype in the placenta of female fetuses in aged rats may be partly 
mediated by the altered expression of the IGF2. The Igf2 gene is important for the differentiation of glycogen 
cells and expression placental lactogen 2 in the rodent placenta50–52. It also promotes the morphogenesis of the 
Lz and regulates the expression of System A amino acid transporters, including Slc38a4 in mice53,54. Studies in 
mice, rats, guinea pigs and non-human primates have shown that expression of Igf2 correlates with phenotypic 
changes in the placenta in response an altered maternal environment (reviewed in35). Furthermore, previous work 
has shown that placental Igf2 is essential for the placenta to morphologically and functionally adapt to mater-
nal undernutrition in mice55. In the current study, the expression of the Igf2 gene was increased in female, but 
unchanged male placentas of aged dams. This is in line with previous work showing that placental Igf2 transcript 
expression is more responsive in females than males when the gestational environment is unfavourable39,43,56. 
However, in the current study, placental IGF2 protein abundance was unchanged in females and reduced in 
males in response to advanced maternal age. The mechanisms underlying the sexually-disparate response and 
discrepancy between the gene and protein expression of Igf2/IGF2 in the placenta of aged dams require further 
investigation. Furthermore, additional work is required to define the contribution of changes in placental Igf2/
IGF2 to the morphological and functional phenotype of the placenta from female and male fetuses of aged dams.
Phenotypic responses of the placenta in aged rats may also relate to changes in the placental handling of 
maternal glucocorticoids. Previous studies have shown that increased exposure to glucocorticoids compromises 
Female Male
Young Aged Young Aged
Barrier thickness (µm)
3.48 ± 0.21 3.17 ± 0.40 3.09 ± 0.14 3.82 ± 0.35
Surface area (cm2)
MBS 4.1 ± 0.71 3.38 ± 0.51 3.24 ± 0.34 4.06 ± 0.90
FC 2.21 ± 0.26 3.34 ± 0.62 2.10 ± 0.18 2.31 ± 0.55
TDC (mm2/min/kPa)
0.00118 ± 0.00021 0.00134 ± 0.00025 0.00115 ± 0.00013 0.00119 ± 0.00035
Table 3. Placental exchange characteristics in young versus aged dams. Data are from 4 placentas each from a 
different litter per group and are presented as mean ± SEM. No significance was detected between young and 
aged dams by unpaired t-test. TDC: total diffusing capacity.
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placental development57,58 and induces apoptosis specifically in the Jz59. It also perturbs Vegf60, placental lactogen, 
Igf261 and system A amino acid transporter expression in the rodent placenta57,58,62. Moreover, antenatal gluco-
corticoids induce oxidative stress in the human placenta of male infants63. The disparity of the placental response 
to advanced maternal age with fetal sex may therefore relate to differences in the expression of 11β-hsd2 by the 
placenta in female and males of young rats seen herein. Most notably, they may also be linked to the observation 
that in female fetuses of aged dams, increased 11β-hsd2 and decreased 11β-hsd1 expression by the placenta would 
have limited feto-placental exposure to maternal glucocorticoids, whereas in male fetuses, reduced placental 
11β-hsd2 and maintained 11β-hsd1 expression would have increased glucocorticoid exposure of the concep-
tus. Previous work in sheep, pigs and rodents have shown that other adverse maternal environments, including 
Figure 3. Placental gene and protein expression in young versus aged dams. Expression of growth regulatory 
(A), nutrient transporter (B), placental lactogen (C) and glucocorticoid metabolism (D) genes in placentas 
from female and male fetuses. Western blot images of IGF2, VEGF and 11-βHSD2 (E) abundance in female and 
male placentas with quantification of proteins adjusted for Ponceau S staining (F–H, respectively). For gene 
expression analyses, data are from 10–12 placentas from 5 litters per group and for protein abundance, data are 
from 4–5 placentas each from different litter. All data are presented as mean + SEM values. Significant difference 
between young and aged dams were determined by unpaired student t test, *p < 0.05.
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malnutrition, obesity, stress and hypoxia reduce placental 11β-hsd2 expression42,64–67, however only few have 
considered the influence of fetal sex43,68,69.
The sex-dependent changes in placental glucocorticoid handing induced by advanced maternal age may also 
explain offspring outcomes. Work in small and large animal models has demonstrated that elevated prenatal 
Figure 4. Placental oxidative stress and apoptosis in young versus aged dams. Images of entire immunoblots 
showing oxidatively damaged proteins (A) with protein quantitation (B) in females and males. Western blot 
images of antioxidant enzymes GPX1, SOD2 and CAT (C) in female and male placentas with abundance of 
proteins adjusted for Ponceau S staining (D). Representative images of sections showing cleaved caspase 3 
immunohistochemistry in the junctional zone (E) and labyrinthine zone (F) with abundance quantified (G,H, 
respectively) in female and male placentas. Representative images of sections showing Tunel staining (I) with 
abundance quantified in the junctional zone (J) in female and male placentas. Data are from n = 4 placentas per 
group, each from different litter and presented as mean + SEM values. Jz: junctional zone, Lz: labyrinth zone. 
Significant difference between young and aged dams were determined by unpaired student t test, *p < 0.05, 
**p < 0.01.
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exposure to glucocorticoids affects fetal development and permanently alters organ structure and function, pre-
disposing to diseases, such as hypertension in the offspring in later life18–20. Indeed, glucocorticoids can affect 
cardiomyocyte differentiation and induce oxidative stress in tissues including the heart and vasculature70. Even 
though fetal weight was similarly compromised for female and male fetuses from aged dams and both sexes expe-
rience postnatal catch up growth, we have previously found that adult male offspring of aged dams have a greater 
propensity to develop cardiovascular dysfunction as adults, when compared to female offspring23,24. Therefore, 
possible increases in glucocorticoid exposure of the male fetus, via decreased placental 11β-hsd2 may have con-
tributed to the programming of cardiovascular dysfunction seen specifically in male offspring of aged dams. 
However, caution is warranted when interpreting changes in placental glucocorticoid handing during gestation in 
aged rat dams. In particular, and despite changes in gene expression, placental 11β-HSD2 abundance only tended 
to be elevated (non-significant) in females and was unchanged in males of aged dams. Therefore, further work is 
required to assess more directly the role of placental glucocorticoid handling in placenta phenotype and offspring 
outcome of females and males from aged dams.
The current study applied morphological and molecular (gene and protein expression) approaches to assess 
phenotypic changes in the placenta of female and male fetuses in response to advanced maternal age in the rat. 
However, further studies assessing the transport, endocrine and barrier functions of the placenta using in vivo 
and isolated organ approaches in aged dams are warranted. In the current study, only one gestational timepoint 
(GD20) was assessed in our rat dams. Although others have shown that there are morphological and transcrip-
tional changes in the placenta of aged dams compared to young dams earlier in gestation, on GD11.5 in the 
mouse12. Thus, it is likely that some changes in placental phenotype with maternal age in our rat dams may 
emerge much earlier in gestation and hence, a time-course of the phenotypic changes in the placenta and fetal 
growth with advanced maternal age are needed in future work. In rodents, direct conclusions between placental 
traits and offspring outcome are challenging. Thus, there is much to be gained by analysing placental phenotype 
with subsequent follow-up of the child in women of advanced maternal age.
In summary, advanced maternal age affects the phenotype of the rat placenta in a sex-dependent manner 
(Fig. 5). In female fetuses from aged dams, there were largely beneficial changes in structure and/or expression of 
genes related to the function of both the placental transport and endocrine zone, which would aid materno-fetal 
nutrient transfer and were related to the up-regulation of Igf2 and improved glucocorticoid handling in the pla-
centa of aged dams, compared to young dams. Whereas, in male fetuses of aged rats, there were no beneficial 
changes in placental transport zone formation or hormone expression and reduced IGF2 when compared to 
placentas from young dams. There also appeared to be diminished protection of the conceptus from glucocor-
ticoids, greater induction of oxidative stress (compared with female even though the placenta of females had 
reduced CAT abundance), and elevated levels of apoptosis in the male placenta of aged rats. The maternal and 
sex-dependent fetal signals driving changes in placenta phenotype in aged dams require elucidation. However, the 
sexually-divergent changes in placental responses to the environment provided by an aged mother, likely play a 
central role in determining health outcomes of female and male offspring23,24. These results have implications for 
the management human pregnancies, particularly in developed countries where women are more often entering 
pregnancy at an older age.
Methods
Animal ethics and aged model. Rat experiments were conducted under the Canadian Council on Animal 
Care guidelines and were approved by the University of Alberta Health Sciences Animal Policy and Welfare 
Committee. All experimental protocols conformed to the National Institutes of Health’s Guide for the Care and 
Use of Laboratory Animals (eighth edition, revised 2011).
Sprague Dawley female rats (3 months of age) were purchased from Charles River (St. Constant, QC) and 
housed in a temperature-controlled room with a 10:14 h light: dark cycle. Female rats were randomly allocated 
to the young (3–4 months old) or aged (9.5–10 months old) group, corresponding to approximately 35 years of 
age in humans (i.e. defined for humans as advanced maternal age) when considering such milestones as weaning, 
sexual maturity, skeletal maturity and reproductive senescence69, and were mated with young males (3–5 months 
old). To control for differences in body weight, dams for the aged group were kept on a controlled-feeding regime 
until pregnancy. Young rats were fed ad libitum throughout the study. Aged rats were maintained on a controlled 
feeding regime from 3 months of age until pregnancy, when they were also fed ad libitum. In the controlled 
feeding regime, rats were fed 6 pellets of chow per rat per day, based on the National Research Council recom-
mendations71. As rats were housed in pairs, they were weighed weekly to ensure they did not lose weight. Pairs 
were rotated if this occurred. The presence of sperm in a vaginal smear indicated mating had occurred and was 
designated as GD 0 out of 22 days of rat pregnancy. At GD 20, dams were anesthetized with isoflurane and killed 
by cardiac exsanguination. Maternal blood was kept for serum measurement of metabolite and hormone concen-
trations. Litter size, number of viable and resorbing fetuses, and placental, fetuses and fetal organs weights were 
recorded. Placentas were bisected and fixed in paraformaldehyde for morphological assessment or snap frozen for 
molecular analysis. Frozen placentas were pulverized for RNA, DNA and protein extraction.
fetal sex determination. Due to time and technical constraints at the post-mortems, many, but not 
all the conceptuses within each litter were collected for sex determination. Fetal sex was determined using 
extracted placental DNA and PCR amplification of the Sry (primers: 5′-TACAGCCTGAGGACATATTA-3′ 
an d  5 ′ - G C AC T T TA AC C C T TC G ATG A- 3 ′ ;  pro du c t  s i z e :  3 1 7  bp )  an d  Ac t in  ( pr i m e r s : 
5′-AGCCATGTACGTAGCCATCC-3′ and 5′-TGTGGTGGTGAAGCTGTAGC-3′; product size: 220 bp). PCR 
products were visualised by electrophoresis using 2% agarose gels using iBright imaging system (Thermo Fisher 
scientific, UK).
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Maternal serum metabolites and hormones. Plasma glucose, leptin, insulin, triglycerides, cholesterol 
and non-esterified free fatty acids concentrations were determined by immuno and enzymatic assays as described 
previously by72.
placental morphological analysis. Fixed placentas were paraffin-embedded and exhaustively sectioned 
at 7 μm. At least 10 sections representing the entire placental sample were stained with hematoxylin and eosin 
to determine gross placental structure using superimposed grids and point counting as described previously36. 
Mid-line placental sections stained with hematoxylin and eosin were also used to assess junctional zone morphol-
ogy as described previously36.
Morphology of the labyrinth region was assessed by double-labelling placental sections with rabbit antibodies 
against cytokeratin (180059, Thermo-Fisher Scientific, UK) and laminin (ab11575, abcam, UK) to identify troph-
oblast and fetal capillaries, respectively as previously described73. Slides were dewaxed, rehydrated and endog-
enous peroxidase quenched by incubation in 3% (v/v) hydrogen peroxide for 10 min. Sections were subjected 
to antigen retrieval by microwave heating in citrate buffer (pH 6) for 30 min, washed by three 5 min rinses in 
phosphate buffered saline (PBS), blocked in 1% bovine serum albumin (BSA) and incubated overnight with 
anti-laminin antibody (1:200 dilution in 1% BSA/PBS). The following day, goat anti-rabbit secondary antibody 
Figure 5. Summary illustration showing the effects of maternal age on the placenta, fetus and offspring (at 
4 month and 12 months of age as published in Cooke et al.23 and Shah et al.24) for females and males. Gly-T: 
glycogen cells, Jz: junctional zone, Lz: labyrinthine zone, Sp-T: spongiotrophoblast, Troph: trophoblast.
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(Abcam, ab6720; 1:1000, 1% BSA/PBS) was then added for 1 h followed by streptavidin-horse radish peroxidase 
complex (Strep-HRP Rockland, S000-03, 1:500 in PBS) for 1 h. Laminin was visualised by staining with diami-
nobenzidine (DAB; ab64238, Abcam, UK) in saturated ammonium nickel (II) sulphate solution. Sections were 
then washed, re-blocked in 10% goat serum in 1% BSA and incubated overnight with anti-cytokeratin antibody 
(1:100 in 10% goat serum and 1% BSA/PBS). Goat anti-rabbit secondary antibody (1:1000, 1% BSA/PBS) was 
then applied for 1 h, washed and Strep-HRP added. DAB was applied to the sections. Samples were then coun-
terstained with hematoxylin and eosin and mounted in DPX. Eosin helped to identify maternal blood spaces in 
the labyrinth. Negative control sections were prepared by omission of the primary antibodies. Point counting 
was used to determine the volume densities of each labyrinth component (fetal capillary, maternal blood space, 
trophoblast). Labyrinthine fetal capillary length density, total capillary length and diameter were obtained using 
counting frames. The thickness of the interhemal membrane and surface area were determined using lines and 
cycloid arcs at random starting locations within the labyrinthine zone. The theoretical diffusion capacity was 
calculated using the surface area, divided by the interhemal barrier thickness and multiplied by Krogh’s constant 
for oxygen diffusion (17.3 × 10−8 cm2 min−1 kPa−1).
placental levels of cell apoptosis. Placental apoptosis was also determined in mid-line placental sections 
by immuno-labelling with an antibody against cleaved caspase-3 (#9661, cell signalling, MA, USA) using the 
immunohistochemistry protocol described above. In addition, an in situ cell death detection kit, tetramethyl-
rhodamine red (TMR red; Roche, UK) followed by DAPI staining was used to detect the end stage of apoptosis 
following the manufacturer’s protocol. Cells positive for cleaved caspase-3 or TMR red were counted using ImageJ 
software and calculated as percentage of total cells.
placental gene expression assessment. Gene expression was analysed by real-time PCR (7500 fast 
real-time PCR system; Applied Biosystems, Cheshire, UK) on RNA isolated from 20 mg of powdered placenta 
using a RNeasy Plus Mini Kit (Qiagen, Crawley, UK) and reverse-transcribed to cDNA using MultiScribe reverse 
transcriptase with random primers (Applied Biosystems, Cheshire,UK). Samples were analysed in duplicate 
using SYBR Green chemistry (MESA Blue qPCR MasterMix, Eurogentec, UK) with gene-specific primers listed 
in Table 4. The qPCR products were verified by gel electrophoresis and sequencing. The 2−ΔΔCT method for 
Transcript Primers Reference
Slc2a1
F: 5′-GCTGTGGCTGGCTTCTCTAA-3′
R: 5′-CCGGAAGCGATCTCATCGAA-3′
Slc2a3
F: 5′-ACCTGATTGCCATCCTTGGG-3′
R: 5′-AACGATGCCCAGCTGGTTTA-3′
Slc38a1
F: 5′-CGGCGCCTTTCCCTTTATTTC-3′
R: 5′-CCGTTAACTCGAGGCCACTT-3′
Slc38a2
F: 5′-TTCTGATTGTGGTGATTTGCAAGAA-3′
R: 5′-CAGGATGGGCACAGCATACA-3′
Slc38a4
F: 5′-AAGGTAGAGGCGGGAAAGGG-3′
R: 5′-AGGAACTTCTGACTTTCGGCA-3′
Igf2
F: 5′-GTCGATGTTGGTGCTTCTCA-3′ 74
R: 5′-AAGCAGCACTCTTCCACGAT-3′
Vegf
F: 5′-TCACCGGAAAGACCGATTAAC-3′
R: 5′-CCCTTCATGTCAGGCTTTCT-3′
P53
F: 5′-CCATCCTTACCATCATCACGCTG-3′
R: 5′-GGCACAAACACGAACCTCAAAG-3′
Prl3d1
F: 5′-TTCGGGCTCTGGTATGCAAC-3′ 75
R: 5′-TGGACACAATGGCAGTTGGTTTGG-3′
Prl3b1
F: 5′-ACCATGCTTCTCTGGGACACT-3′ 76
R: 5′-AGGCTTCCAGTGGACATTCGGTAA-3′
Hsd11b1
F: 5′-GAAGAAGCATGGAGGTCAAC-3′ 77
R: 5′-GCAATCAGAGGTTGGGTCAT-3′
Hsd11b2
F: 5′-TGGCCAACTTGCCTAGAGAG-3′ 78
R: 5′-TTCAGGAATTGCCCATGC-3’
L19
F: 5′-CTGAAGGTCAAAGGGAATGTG-3′ 74
R: 5′-GGACAGAGTCTTGATGATCTC-3′
Hprt1
F: 5′-GCCTAAAAGACAGCGGCAAG-3′
R: 5′-GGCTGCCTACAGGCTCATAG-3′
Sdha
F: 5′-TACTGTTGCAGCACAGGGAG-3′
R: 5′-TCAGTCCTGCTAAACGGCAT-3′
Table 4. PCR primers used for quantification of mRNA expression by real-time RT-PCR with corresponding 
references, where required.
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quantification was used for the genes of interest and normalized to the geometric mean expression levels of L19, 
Hprt and Sdha, which were unaffected by maternal age.
Placental protein abundance analysis. Placentas from 4–5 dams were separated by sex for analysis of 
protein expression by Western blot. Total protein was extracted using RIPA buffer (Thermo Fisher Scientific, MA, 
USA) according to manufacturer’s protocol. Lysate protein concentrations were determined using a Bradford 
assay (Sigma-Aldrich, St. Louis, MO). Equivalent amounts of protein (60 μg) were resolved by SDS-PAGE, blot-
ted onto nitrocellulose (0.2 μm), and analyzed by enhanced chemiluminescence, SuperSignal™ ELISA Femto 
Substrate (Thermo Fisher Scientific, MA, USA). Intensities of the bands representing IGF2 (ab9574), VEGF 
(ab46154), 11-βHSD2 (ab80317), GPX1 (ab16798), Catalase (ab1877) (abcam, Cambridge, UK) and Mn-SOD 
(#06-984, Sigma-Aldrich, Dorset, UK) were determined using iBright analysis software (Thermo Fisher Scientific, 
MA, USA). Protein loading was controlled for by dividing the measured signal of the bands by that of the 
Ponceau-S-stained membrane.
placental protein oxidation assay. Total protein oxidation levels were detected using OxyBlotTM pro-
tein oxidation detection kit (Millipore, Watford, UK) according to manufacturer’s protocol. In brief, proteins 
were extracted from 60 mg of powdered placenta using lysis buffer. 15 µg of extracted placental protein was then 
derivatized by 2,4-dinitrophenylhydrazine (DNPH) treatment and separated on 12% SDS-PAGE following elec-
troblotting to nitrocellulose membrane. Membrane bands were visualised using iBright imaging system (Thermo 
Fisher scientific, Paisley, UK). Proteins were normalised to ponceau-S staining and quantified by iBright analysis 
software (Thermo Fisher scientific, Paisley, UK).
Statistical analysis. All data are presented as mean + SEM. Data were normally distributed and analysed by 
unpaired Student’s t-tests to assess the effect of maternal age within the one fetal sex, using GraphPad Prism 7.00 
(GraphPad Software, CA, USA). Data were considered statistically significant at values of p < 0.05.
Data availability
All data are available, without restriction, upon request.
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